InvestorsHub Logo
Followers 4054
Posts 151292
Boards Moderated 4
Alias Born 08/05/2009

Re: crudeoil24 post# 102

Friday, 06/29/2018 7:56:50 AM

Friday, June 29, 2018 7:56:50 AM

Post# of 567

“We are eager to return APTO-253 back into the clinic,” said William G. Rice, Ph.D., Chairman, President and Chief Executive Officer. “Our understanding of this molecule has evolved dramatically, and we are excited to deliver a MYC gene expression inhibitor to patients with debilitating hematologic malignancies.”


Always consult an Investment Professional, my posts are my own
opinions, and not for investing decisions!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News